See more : Nxera Pharma Co., Ltd. (SOLTF) Income Statement Analysis – Financial Results
Complete financial analysis of Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fuan Pharmaceutical (Group) Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Wong’s International Holdings Limited (0099.HK) Income Statement Analysis – Financial Results
- Excel Force MSC Berhad (0065.KL) Income Statement Analysis – Financial Results
- Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ) Income Statement Analysis – Financial Results
- Artemis Resources Limited (ARV.L) Income Statement Analysis – Financial Results
- Gensol Engineering Limited (GENSOL.NS) Income Statement Analysis – Financial Results
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.fapharm.com
About Fuan Pharmaceutical (Group) Co., Ltd.
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other products. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. Fuan Pharmaceutical (Group) Co., Ltd. was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.65B | 2.42B | 2.45B | 2.37B | 2.78B | 2.67B | 2.09B | 1.30B | 708.10M | 448.57M | 357.78M | 420.02M | 358.55M | 464.01M | 324.53M | 198.46M | 93.44M |
| Cost of Revenue | 1.23B | 1.01B | 911.47M | 819.52M | 1.01B | 1.02B | 911.41M | 688.44M | 395.12M | 305.79M | 241.33M | 269.41M | 215.26M | 248.38M | 167.24M | 112.93M | 72.70M |
| Gross Profit | 1.41B | 1.41B | 1.54B | 1.55B | 1.77B | 1.65B | 1.18B | 608.58M | 312.97M | 142.78M | 116.45M | 150.60M | 143.29M | 215.63M | 157.29M | 85.53M | 20.74M |
| Gross Profit Ratio | 53.36% | 58.37% | 62.85% | 65.40% | 63.74% | 61.67% | 56.41% | 46.92% | 44.20% | 31.83% | 32.55% | 35.86% | 39.96% | 46.47% | 48.47% | 43.10% | 22.20% |
| Research & Development | 148.79M | 142.89M | 120.38M | 86.94M | 108.02M | 119.76M | 96.64M | 52.41M | 17.81M | 8.83M | 11.48M | 10.48M | 4.89M | 8.13M | 6.20M | 1.85M | 1.28M |
| General & Administrative | 66.58M | 61.74M | 49.27M | 51.76M | 43.59M | 39.25M | 39.85M | 31.39M | 28.93M | 20.70M | 19.77M | 19.89M | 12.95M | 10.25M | 10.95M | 6.63M | 2.33M |
| Selling & Marketing | 753.80M | 881.07M | 1.02B | 1.07B | 1.21B | 1.07B | 583.20M | 140.16M | 118.35M | 26.58M | 21.86M | 17.20M | 14.42M | 16.79M | 13.27M | 7.69M | 3.31M |
| SG&A | 820.38M | 942.81M | 1.07B | 1.12B | 1.26B | 1.11B | 623.05M | 171.55M | 147.28M | 47.28M | 41.63M | 37.10M | 27.37M | 27.04M | 24.22M | 14.32M | 5.64M |
| Other Expenses | 145.31M | 10.83M | -986.84K | 351.99K | 181.00K | -1.52M | 4.71M | 6.14M | 4.55M | 2.63M | 3.92M | 8.14M | 4.20M | 970.86K | 4.37M | -82.31K | -41.52K |
| Operating Expenses | 1.11B | 1.25B | 1.35B | 1.35B | 1.49B | 1.37B | 859.18M | 343.80M | 242.32M | 107.94M | 96.94M | 86.82M | 60.66M | 67.87M | 51.48M | 26.44M | 10.88M |
| Cost & Expenses | 2.35B | 2.25B | 2.26B | 2.17B | 2.50B | 2.40B | 1.77B | 1.03B | 637.45M | 413.73M | 338.27M | 356.23M | 275.92M | 316.25M | 218.72M | 139.37M | 83.57M |
| Interest Income | 32.02M | 28.32M | 22.73M | 17.07M | 19.38M | 9.29M | 2.08M | 3.06M | 7.58M | 20.84M | 26.43M | 36.14M | 28.97M | 311.66K | 1.44M | 74.35K | -0.50 |
| Interest Expense | 30.39M | 26.94M | 20.45M | 10.16M | 2.40M | 1.55M | 1.19M | 12.65M | 7.00M | 415.33K | 923.33K | 433.13K | 499.89K | 1.67M | 3.44M | 2.86M | 3.38M |
| Depreciation & Amortization | 209.79M | 185.40M | 211.70M | 156.47M | 145.27M | 142.48M | 149.83M | 121.33M | 85.15M | 46.17M | 34.30M | 28.55M | 16.33M | 12.04M | 9.83M | 6.07M | 2.87M |
| EBITDA | 528.99M | 340.62M | -409.89M | 407.06M | 473.15M | -186.79M | 483.36M | 391.29M | 170.40M | 100.58M | 79.44M | 134.19M | 130.48M | 159.59M | 122.26M | 63.02M | 12.74M |
| EBITDA Ratio | 19.98% | 18.72% | 18.01% | 17.31% | 17.39% | 16.66% | 23.33% | 30.76% | 25.16% | 23.85% | 23.82% | 32.48% | 36.82% | 34.70% | 37.37% | 32.82% | 14.21% |
| Operating Income | 298.49M | 178.53M | -591.00M | 240.77M | 326.59M | -321.14M | 329.17M | 255.76M | 77.96M | 53.80M | 43.28M | 98.28M | 111.30M | 145.47M | 105.42M | 54.22M | 5.95M |
| Operating Income Ratio | 11.27% | 7.37% | -24.09% | 10.17% | 11.74% | -12.03% | 15.74% | 19.72% | 11.01% | 11.99% | 12.10% | 23.40% | 31.04% | 31.35% | 32.49% | 27.32% | 6.37% |
| Total Other Income/Expenses | -8.13M | 10.83M | -986.84K | 351.99K | 181.01K | -1.52M | 4.71M | 1.57M | -1.59M | 190.56K | 939.69K | 42.45M | 30.72M | 404.59K | 3.57M | -2.93M | -44.61K |
| Income Before Tax | 290.36M | 189.35M | -591.99M | 241.12M | 326.77M | -322.66M | 333.89M | 257.33M | 76.37M | 53.99M | 44.22M | 105.21M | 113.65M | 145.87M | 109.00M | 54.08M | 5.91M |
| Income Before Tax Ratio | 10.97% | 7.82% | -24.13% | 10.18% | 11.75% | -12.09% | 15.97% | 19.84% | 10.79% | 12.04% | 12.36% | 25.05% | 31.70% | 31.44% | 33.59% | 27.25% | 6.32% |
| Income Tax Expense | 55.95M | -11.47M | 17.61M | 35.35M | 33.74M | 37.27M | 49.09M | 35.21M | 10.82M | 8.13M | 5.62M | 15.70M | 18.18M | 21.15M | 15.93M | 8.61M | 236.31K |
| Net Income | 231.87M | 204.61M | -296.91M | 209.37M | 292.83M | -359.98M | 284.81M | 221.96M | 64.90M | 45.71M | 38.37M | 88.51M | 95.23M | 123.14M | 90.67M | 45.70M | 5.36M |
| Net Income Ratio | 8.76% | 8.45% | -12.10% | 8.84% | 10.53% | -13.49% | 13.62% | 17.11% | 9.17% | 10.19% | 10.72% | 21.07% | 26.56% | 26.54% | 27.94% | 23.03% | 5.74% |
| EPS | 0.19 | 0.17 | -0.25 | 0.18 | 0.25 | -0.30 | 0.24 | 0.19 | 0.08 | 0.06 | 0.05 | 0.11 | 0.13 | 0.21 | 0.16 | 0.22 | 0.57 |
| EPS Diluted | 0.19 | 0.17 | -0.25 | 0.18 | 0.25 | -0.30 | 0.24 | 0.19 | 0.08 | 0.06 | 0.05 | 0.11 | 0.13 | 0.21 | 0.16 | 0.22 | 0.57 |
| Weighted Avg Shares Out | 1.22B | 1.19B | 1.19B | 1.19B | 1.19B | 1.19B | 1.19B | 1.17B | 811.24M | 761.79M | 767.36M | 780.93M | 733.05M | 585.65M | 582.88M | 210.50M | 9.37M |
| Weighted Avg Shares Out (Dil) | 1.22B | 1.19B | 1.19B | 1.19B | 1.19B | 1.20B | 1.19B | 1.17B | 811.24M | 761.79M | 767.36M | 780.93M | 733.05M | 585.65M | 582.88M | 210.50M | 9.37M |
Source: https://incomestatements.info
Category: Stock Reports